By Fineline Cube 
China-based gene sequencing specialist MGI Tech Co., Ltd. (SHA: 688114) has entered into a strategic partnership with Türkiye’s leading clinical gene testing laboratory, Genoks. The collaboration aims to significantly enhance Genoks’ clinical testing service capacity for the local market by introducing MGI’s advanced sequencing platform and supporting products, thereby accelerating the development of local public health initiatives and genomics research.
Partnership Details
Through this partnership, MGI’s proprietary DNBSEQ sequencing technology will provide robust support for Genoks’ comprehensive clinical testing products. These include whole genome sequencing (WGS), whole exome sequencing (WES), carrier screening, genetic cancer screening, and more. The integration of MGI’s technology will enable Genoks to meet a broader range of clinical testing needs, solidifying its position as a key player in Türkiye’s gene testing landscape.-Fineline Info & Tech